Policy
Calculator

Pilot-Phase

1. 'Did you have flu last week?’ A telephone survey to estimate a point prevalence of influenza in the Swedish population;
2. 2014 Failed Influenza Vaccination Winter Campaign;
3. 2019 Influenza Vaccination Campaign in an Italian Research and Teaching Hospital;
4. A campaign aimed at increasing seasonal influenza vaccination coverage among post graduate medical residents in an Italian teaching hospital;
5. A cloud-based simulation architecture for pandemic influenza simulation;
6. A comparative analysis of influenza vaccination programs;
7. A discrete time-space geography for epidemiology;
8. A flexible simulation architecture for pandemic influenza simulation;
9. A global map of hemispheric influenza vaccine recommendations based on local patterns of viral circulation;
10. A neighborhood susceptibility index for planning of local physical interventions in response to pandemic influenza outbreaks;
11. A network strategy to advance public health in Europe;
12. A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre;
13. A randomized trial of maternal influenza immunization decision-making;
14. A review of the pharmacist as vaccinator;
15. A systematic review of the health economic consequences of quadrivalent influenza vaccination;
16. Age as a determinant for dissemination of seasonal and pandemic influenza;
17. Algorithms for detecting and predicting influenza outbreaks;
18. An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model;
19. An effective strategy for influenza vaccination of healthcare workers in Australia;
20. An evaluation of the 2016 influenza vaccination in pregnancy campaign in NSW, Australia;
21. An intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses;
22. An overview of current pharmacy impact on immunisation - A global report;
23. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate;
24. Approaches to the vaccination of pregnant women;
25. Are age-based strategies effective in increasing influenza vaccination coverage? The Spanish experience;
26. Association between recruitment methods and attrition in internet-based studies;
27. Association of acute myocardial infarction with influenza;
28. Association of state laws and healthcare workers' influenza vaccination rates;
29. Attitudes and beliefs on influenza vaccination during the covid-19 pandemic;
30. Attitudes and perception of healthcare workers concerning influenza vaccination during the 2019/2020 season;
31. Attractive VCR-linked financial incentive for HCP;
32. Brief education to promote maternal influenza vaccine uptake;
33. Burden of medically attended influenza in Norway 2008-2017;
34. Campaign, counseling and compliance with influenza vaccine among older persons;
35. Changing the default to promote influenza vaccination among health care workers;
36. Chasing seasonal influenza — The need for a universal influenza vaccine;
37. Closure of schools during an influenza pandemic;
38. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care;
39. Communicable diseases prioritized according to their public health relevance;
40. Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach;
41. Contemporary vaccination policy in the European Union;
42. Correlation between mandatory influenza vaccination for healthcare;
43. Cost-effectiveness of influenza vaccination of elderly in Sweden;
44. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy;
45. Costs and effectiveness of influenza vaccination;
46. Dealing with ecological fallacy in preparations for influenza pandemics;
47. Description of the Western Sydney and Nepean Blue Mountains local health districts’ influenza prevention programme;
48. Determinants of fatal outcome in patients admitted to intensive care units with influenza;
49. Determinants of follow-up participation in the internet-based european influenza surveillance platform influenzanet;
50. Determinants of influenza vaccination uptake among Italian healthcare workers;
51. Developing a program to increase seasonal influenza vaccination of healthcare workers: lessons from a system of community hospitals;
52. Does viral interference affect spread of influenza?;
53. Duration of influenza vaccine effectiveness;
54. Dynamic multicore processing for pandemic influenza simulation;
55. ECDC Threat Assessment Influenza of possible swine origin in human in Spain;
56. Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden;
57. Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population;
58. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales;
59. Effect of motivational team on influenza vaccination coverage among health care workers;
60. Effectiveness and acceptance of a health care-based mandatory vaccination program;
61. Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings;
62. Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain);
63. Effectiveness of an educational intervention on seasonal influenza vaccination campaign adherence among healthcare workers of the Palermo University Hospital, Italy;
64. Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes;
65. Effectiveness of influenza vaccines in preventing severe influenza illness among adults;
66. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly;
67. Effectiveness of the influenza vaccination program for the elderly in Taiwan;
68. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10;
69. Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults;
70. Efficacy and effectiveness of influenza vaccines;
71. Efficacy and safety of high-dose influenza vaccine in elderly adults;
72. Emergency Department influenza vaccination campaign allows increasing influenza vaccination coverage without disrupting time interval quality indicators;
73. Employee influenza vaccination in a large cancer center with high baseline compliance rates;
74. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic;
75. Estimated costs associated with improving influenza vaccination for health care personnel in a multihospital health system;
76. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis;
77. Ethical approaches to mandating inflfluenza vaccinations for local health department workforce in Georgia;
78. European all-cause excess and influenza-attributable mortality in the2017/18 season;
79. Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model;
80. Evaluating influenza vaccination campaigns beyond coverage;
81. Evaluating the importance of policy amenable factors in explaining influenza vaccination;
82. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza;
83. Evaluation of an internet-based monitoring system for influenza-like illness in Sweden;
84. Evaluation of employee vaccination policies in outpatient oncology clinics;
85. Evaluation of nowcasting for detecting and predicting local influenza epidemics, Sweden, 2009–2014;
86. Evaluation of the Canterbury under-18 seasonal influenza vaccination programme;
87. Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016;
88. Evaluation of the impact of the 2012 Rhode Island health care worker influenza vaccination regulations;
89. Examination of the British Columbia influenza prevention policy for healthcare workers;
90. Exploring indirect protection associated with influenza immunization;
91. Extensive hospital in-ward clustering revealed by molecular characterization of influenza a virus infection;
92. Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study;
93. Feasibility of a pharmacy-based influenza immunization program in an academic emergency department;
94. Flocked nasal swab versus nasopharyngeal aspirate in adult emergency room patients;
95. Flu vaccination - The gap between evidence and public policy;
96. Gender, Socioeconomic, and Health Characteristics Associated with Influenza Vaccination Coverage (VC) among Italian Healthcare Workers: Secondary Analysis of a National Cross-Sectional Survey;
97. General practitioners perceptions about financial and non-financial incentives to improve influenza vaccination coverage rates in France;
98. GP procurement for the flu vaccination programme;
99. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study;
100. Healthcare worker influenza declination form program;
101. High added value of a population-based participatory surveillance system for community acute gastrointestinal, respiratory and influenza-like illnesses in Sweden;
102. High prevalence of influenza A virus in ducks caught during spring migration through Sweden;
103. Higher all-cause mortality in children during autumn 2009 compared with the three previous years;
104. Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands;
105. How to implement seasonal influenza vaccination of health workers;
106. How to respond to vocal vaccine deniers in public;
107. Human cases of avian influenza in eastern Turkey;
108. Immunisation of healthcare workers in the Nordic countries: Variation in recommendations and practices and a lack of assessment;
109. Immunization of health-care providers - Necessity and public health policies;
110. Impact of education program on influenza vaccination rates in Spain;
111. Impact of elementary school-located influenza vaccinations;
112. Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population;
113. Impact of pharmacist administration of influenza vaccines on uptake in Canada;
114. Impact of pharmacist immunization authority on seasonal influenza immunization rates across states;
115. Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, Canada;
116. Impact of pharmacy-initiated interventions on influenza vaccination rates in pediatric solid organ transplant recipients;
117. Impact of precautionary behaviors during outbreaks of pandemic influenza;
118. Impact of the flu mask regulation on health care personnel influenza vaccine acceptance rates;
119. Impact of the GP contract on inequalities associated with influenza immunisation;
120. Impacting delayed pediatric influenza vaccination;
121. Implementation of a mandatory influenza vaccine policy- a 10-year experience;
122. Implementation of the Council Recommendation on seasonal influenza vaccination (2009/1019/EU);
123. Improving influenza vaccination coverage among patients with COPD;
124. Improving influenza vaccination rates of healthcare workers;
125. Improvinginfluenzavaccinationuptakeamonghealthcareworkersbyon- site influenza vaccination campaign in a tertiary children hospital;
126. Improving Influenza vaccine uptake in frontline staff;
127. Incidence, etiology, and outcomes of community-acquired pneumonia;
128. Inclusion of social media-based strategies in a health care worker influenza immunization campaign;
129. Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of U.S. hospitals;
130. Increasing childhood influenza vaccination;
131. Increasing influenza and pneumococcal vaccination uptake in seniors using point-of-care informational interventions in primary care in Singapore;
132. Increasing influenza immunization rates among healthcare providers in an ambulatory-based, University healthcare setting;
133. Increasing influenza vaccination acceptance in the homeless;
134. Increasing influenza vaccination rates via low cost messaging interventions;
135. Increasing influenza vaccine uptake in children;
136. Increasing inner-city adult influenza vaccination rates;
137. Inference principles for multivariate surveillance;
138. Influenza burden of illness: estimates from a national prospective survey of household contacts in France;
139. Influenza coverage rates in subjects with chronic heart diseases;
140. Influenza detection and prediction algorithms;
141. Influenza in Sweden 2018–2019 Season;
142. Influenza in Sweden 2019–2020 Season;
143. Influenza vaccination and its association with clinic use of evidence- based practices and individual patient characteristics;
144. Influenza Vaccination Coverage Among Health Care Personnel;
145. Influenza vaccination coverage among high-risk groups in 11 European countries;
146. Influenza vaccination coverage among splenectomized patients;
147. Influenza vaccination coverage of health care personnel in Los Angeles County hospitals;
148. Influenza vaccination in health-care workers;
149. Influenza Vaccination in Italian Healthcare Workers (2018-2019 Season): Strengths and Weaknesses. Results of a Cohort Study in Two Large Italian Hospitals;
150. Influenza vaccination in Turkey: Prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate;
151. Influenza vaccination of health care workers - Policies and practices of hospitals in a community setting;
152. Influenza vaccination of healthcare workers in Italy - could mandatory vaccination be a solution to protect patients;
153. Influenza vaccination of schoolchildren and influenza outbreaks in a school;
154. Influenza vaccination strategies for 2020-21 in the context of COVID-19;
155. Influenza vaccination: Key facts for general practitioners in Europe;
156. Influenza vaccine coverage and reasons for non-vaccination in a sample of people above 65 years of age;
157. Influenza vaccine effectiveness against influenza-associated hospitalization in children;
158. Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies; 159. Influenza vaccines: Evaluation of the safety profile;
159. Influenza-related healthcare visits, hospital admissions, and direct medical costs for all children aged 2 to 17 years in a defined Swedish region, monitored for 7 years;
160. Initial epidemiological finding in the european union following the declaration of pandemic alert level 5 due to influenza A(H1N1);
161. Integrated detection and prediction of influenza activity for real-time surveillance;
162. Intentions to perform non-pharmaceutical protective behaviors during influenza outbreaks in Sweden;
163. Interactive Voice Response and web-based questionnaires for population-based infectious disease reporting;
164. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020;
165. Intervening to reduce inequalities in infections in Europe;
166. Interventions to increase influenza vaccination rates in children with
167. high-risk conditions;
168. Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries;
169. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels;
170. Let’s talk about hesitancy;
171. Management of community-acquired pneumonia in immunocompetent adults;
172. Management of two influenza vaccination campaign in health care workers of a university hospital in the south Italy;
173. Mandated influenza vaccines and health care workers’ autonomy;
174. Mandating influenza vaccinations for health care workers;
175. Mandatory influenza vaccination of healthcare workers: a 5-year study;
176. Mandatory policies for influenza vaccination;
177. MandatoryseasonalinfluenzavaccinationormaskingofBritish Columbia health care workers;
178. Mandatory vaccination for health care workers;
179. Maximising the public health benefits of vaccination;
180. Maximizing influenza vaccination uptake among healthcare personnel in Israel;
181. Minority of U.S. hospitals mandate flu vaccination;
182. Modeling influenza incidence for the purpose of on-line monitoring;
183. Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom;
184. Modelling the optimal target age group for seasonal influenza vaccination in Japan;
185. Moving the needle on nursing staff influenza vaccination in long-term care;
186. Multicomponent interventions to enhance influenza vaccine delivery to adolescents;
187. Multiplex real-time PCR for detection of respiratory tract infections;
188. Multivariate outbreak detection;
189. National Board of Health and Welfare – database;
190. Novel influenza a(H1n2) seasonal reassortant identified in a patient sample;
191. Nowcasting (short-term forecasting) of influenza epidemics in local settings, Sweden, 2008–2019;
192. Number needed to vaccinate to prevent hospitalizations of pregnant women due to inter-pandemic influenza in Sweden;
193. Ontology based modeling of pandemic simulation scenarios;
194. Optimizing influenza vaccine distribution;
195. Pandemic Influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009;
196. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season;
197. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe;
198. Patient experiences with influenza immunizations administered by pharmacists;
199. Patient’s behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient’s influenza vaccine uptake;
200. Performance of ehealth data sources in local influenza surveillance;
201. Pharmacists able to update GP patient records with flu vaccine data from winter 2019;
202. Pharmacy-based interventions to increase vaccine uptake: Report of a multidisciplinary stakeholders meeting;
203. Point of care experience with pneumococcal and influenza vaccine documentation among persons aged 65 years;
204. Population-based simulations of influenza pandemics;
205. Predictions by early indicators of the time and height of the peaks of yearly influenza outbreaks in Sweden;
206. Predictive performance of telenursing complaints in influenza surveillance;
207. Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden;
208. Prevention and control of seasonal influenza with vaccines;
209. Promoting influenza vaccination among an ACA Health Plan subscriber population;
210. Promotion of flu vaccination among healthcare workers in an Italian academic hospital;
211. Promotion of influenza vaccination among health care workers;
212. Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens;
213. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe;
214. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine;
215. Quadrivalent inactivated influenza vaccine (VaxigripTetraTM);
216. Randomised controlled trial of a theory-based intervention to prompt front-line staff to take up the seasonal influenza vaccine;
217. Randomized controlled trial of text message reminders for increasing influenza vaccination;
218. Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms;
219. RCT of centralized vaccine reminder/recall for adults;
220. Recommendations for mandatory influenza vaccinations for health care personnel from AMDA’s infection advisory subcommittee;
221. Reducing racial disparities in influenza vaccination among children with asthma;
222. Relevance of workplace social mixing during influenza pandemics;
223. Respiratory viruses associated with community acquired pneumonia in children;
224. Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis;
225. Robust outbreak surveillance of epidemics in Sweden;
226. School-based influenza vaccination: Health and economic impact of Maine’s 2009 Influenza Vaccination Program;
227. School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance;
228. School-located influenza vaccinations for adolescents
229. Seasonal influenza vaccination delivery through community pharmacists in England;
230. Seasonal influenza vaccination in health care workers;
231. Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage;
232. Seasonal influenza vaccine procurement systems in Europe;
233. Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey;
234. Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries;
235. Self-sampling for analysis of respiratory viruses in a large-scale epidemiological study in Sweden;
236. Semiparametric estimation of outbreak regression;
237. Semiparametric surveillance of monotonic changes;
238. Semiparametric surveillance of outbreaks;
239. Simulation as decision support in pandemic influenza preparedness and response;
240. SMS versus telephone interviews for epidemiological data collection;
241. Socioecological and message framing factors influencing maternal influenza immunization among minority women;
242. Some model based considerations on observing generation times for communicable diseases;
243. Spatial outbreak detection based on inference principles for multivariate surveillance;
244. Statistical surveillance of epidemics;
245. Strategies to improve influenza vaccination in pediatric inflammatory bowel disease through education and access;
246. Support among healthcare workers for the new mandatory seasonal influenza vaccination policy and its effects on vaccination coverage;
247. Surveillance of influenza A virus in migratory waterfowl in northern Europe;
248. Swedish nursing and medical students’ high vaccination adherence during the influenza A (H1N1) pandemic 2009;
249. Taking action on asthma;
250. Text messages for influenza vaccination among pregnant women;
251. The case for tracking misinformation the way we track disease;
252. The effect of influenza vaccination for the elderly on hospitalization and mortality;
253. The European Scientific Conference on applied infectious disease epidemiology;
254. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly;
255. The impact of influenza vaccination requirements for hospital personnel in California;
256. The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018;
257. The importance of confidence, complacency, and convenience for influenza vaccination among key risk groups in large urban areas of Peru;
258. The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies;
259. The representativeness of a European multi-center network for influenza-like-illness participatory surveillance;
260. The validity of self-initiated, event-driven infectious disease reporting in general population cohorts;
261. Towards a simulation environment for modeling of local influenza outbreaks;
262. Treatment and prevention of influenza: Swedish recommendations;
263. Understanding non-vaccinating parents’ views to inform and improve clinical encounters;
264. Universal influenza vaccination among healthcare personnel;
265. Uptake of childhood influenza vaccine from 2012-2013 to 2014-2015 in the UK and the implications for high-risk children;
266. Uptake of funded influenza vaccines in young Australian children in 2018;
267. Using general practice data to monitor influenza vaccination coverage in the medically at risk;
268. Using technology to affect influenza vaccine coverage among children with chronic respiratory conditions;
269. Using the 4 Pillars to increase vaccination among high-risk adults;
270. Vaccination and trust;
271. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons;
272. Vaccination rates are associated with functional proximity but not base proximity of vaccination clinics;
273. Vaccination strategies against COVID-19 and the diffusion of anti- vaccination views;
274. Vaccination without litigation — addressing religious objections to hospital influenza-vaccination mandates;
275. Vaccine cold chain in general practices: A prospective study in 75 refrigerators (Keep Cool study);
276. Vaccine hesitancy and healthcare providers;
277. Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies;
278. Vaccines for preventing influenza in healthy adults;
279. Vaccines for preventing influenza in healthy children;
280. Vaccines for preventing influenza in the elderly;
281. Variable influenza vaccine effectiveness by subtype;
282. Visual inspection of vaccine storage conditions in general practices: A study of 75 vaccine refrigerators;
283. Visualization of infectious disease outbreaks in routine practice;
284. Web-based participatory surveillance of infectious diseases;
285. What evidence is there for mandatory flu vaccination for healthcare workers?;
286. Why are Mexican data important?